Company Lipidor AB

Equities

LIPI

SE0012558617

Pharmaceuticals

Delayed Nasdaq Stockholm 14:30:38 15/05/2024 BST 5-day change 1st Jan Change
0.236 SEK +4.89% Intraday chart for Lipidor AB +0.43% -53.17%

Business Summary

Lipidor AB is a Sweden-based drug delivery company focusing on topical medication. The Company is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The Company develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Company’s cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.

Number of employees: 8

Sales per Business

SEK in Million2021Weight2022Weight Delta
Drugs for the Treatment of Skin Diseases
100.0 %
15 100.0 % 0 100.0 % -99.71%

Sales per region

SEK in Million2021Weight2022Weight Delta
Sweden
100.0 %
15 100.0 % 0 100.0 % -99.71%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 31/12/17
Founder 67 31/12/08
Director of Finance/CFO 43 30/09/22
Corporate Officer/Principal - 30/09/20

Members of the board

Members of the board TitleAgeSince
Director/Board Member 61 31/12/18
Director/Board Member 56 31/12/19
Director/Board Member 80 31/12/16
Director/Board Member 62 31/12/19
Chairman 44 31/12/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 28,976,863 18,910,757 ( 65.26 %) 0 65.26 %

Company contact information

Lipidor AB

Karolinska Institutet Science Park Fogdevreten 2

171 65, Solna

+46 7 25 07 03 69

http://www.lipidor.se
address Lipidor AB(LIPI)